Who owns Spectrum Pharmaceuticals?
- CUSIP Number: 84763A108
Tip: Access positions for across all investors
Analyze quarterly positions in Spectrum Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Spectrum Pharmaceuticals stock
Who bought or sold Spectrum Pharmaceuticals this quarter?
There are no current stakeholders of Spectrum Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Spectrum Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Armistice Capital | Jun 2023 | 20M | $19M |
BlackRock | Jun 2023 | 3.5M | $3.3M |
Acadian Asset Management | Jun 2023 | 2.9M | $2.8M |
Ergoteles | Jun 2023 | 2.3M | $2.2M |
Geode Capital Management | Jun 2023 | 1.8M | $1.7M |
Renaissance Technologies | Jun 2023 | 1.4M | $1.4M |
Morgan Stanley | Jun 2023 | 1.1M | $1.1M |
Susquehanna International | Jun 2023 | 721k | $693k |
State Street Corporation | Jun 2023 | 613k | $589k |
Northern Trust | Jun 2023 | 311k | $299k |
Diametric Capital | Jun 2023 | 146k | $140k |
XTX Topco | Jun 2023 | 145k | $139k |